EXPERIMENTAL AND CLINICAL TRANSPLANTATION, vol.13, no.1, pp.35-40, 2015 (Peer-Reviewed Journal)
Article / Article
EXPERIMENTAL AND CLINICAL TRANSPLANTATION
Science Citation Index Expanded, Scopus
Objectives: Chronic hepatitis B virus infection remains a clinical problem for HBsAg (+) kidney transplant recipients. Lamivudine is the approved treatment; however, there are contrary views about optimal initiation. In case of resistance, novel nucleoside analogs should be considered but experience is limited.